Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer[1].
References
[1] Bax HJ, et al. Therapeutic targets and new directions for antibodies developed for ovarian cancer. MAbs. 2016 Nov/Dec;8(8):1437-1455. DOI:10.1080/19420862.2016.1219005
